PRESS RELEASE published on 07/24/2023 at 09:15, 2 years 8 months ago 029 Group SE: Portfolio company TRIP recognized as the 4th fastest growing company in the UK
PRESS RELEASE published on 07/21/2023 at 08:55, 2 years 8 months ago 029 Group SE: Portfolio company Hotelbird introduces a new fully automated kiosk solution
PRESS RELEASE published on 06/29/2023 at 11:39, 2 years 8 months ago EQS-Adhoc: 029 Group SE: Change in the Administrative Board
PRESS RELEASE published on 06/29/2023 at 10:35, 2 years 8 months ago 029 Group SE: Changes in the Administrative Board
PRESS RELEASE published on 04/25/2023 at 22:48, 2 years 11 months ago 029 Group SE: Publication of Annual Report 2022
PRESS RELEASE published on 04/05/2023 at 10:12, 2 years 11 months ago 029 Group SE: portfolio company TRIP named fastest growing drinks brand in the UK
PRESS RELEASE published on 03/08/2023 at 10:04, 3 years ago 029 Group SE: AlsterResearch initiates coverage of 029 Group with ‘Hold’ recommendation
PRESS RELEASE published on 02/07/2023 at 10:21, 3 years 1 month ago 029 Group SE: portfolio company TRIP reports an 800% increase in UK sales throughout January across large retailers
Published on 03/26/2026 at 21:00, 42 minutes ago Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/26/2026 at 21:00, 42 minutes ago Rocky Shore Closes Acquisition of Additional Mining Claims
Published on 03/26/2026 at 16:20, 5 hours 22 minutes ago ACCESS Newswire Upgrades the ACCESS Platform to Include Social Monitoring to Track Brand Conversations Across Major Social Platforms
Published on 03/26/2026 at 13:00, 8 hours 42 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 20:48, 54 minutes ago Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 2 hours 22 minutes ago Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:09, 2 hours 33 minutes ago 2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)
Published on 03/26/2026 at 18:17, 3 hours 25 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 07:30, 14 hours 12 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
